Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) Shares Shorted: Short Interest Down 71.6% in October

Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) was the recipient of a significant drop in short interest during the month of October. As of October 15th, there was short interest totaling 200 shares, a drop of 71.6% from the September 30th total of 705 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average trading volume of 4,414 shares, the short-interest ratio is presently 0.0 days.

Santen Pharmaceutical Stock Performance

Shares of SNPHY remained flat at $11.19 during mid-day trading on Wednesday. 520 shares of the stock were exchanged. The business’s fifty day moving average price is $11.20 and its 200 day moving average price is $11.49. Santen Pharmaceutical has a one year low of $9.22 and a one year high of $13.93.

About Santen Pharmaceutical

Santen Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company focused on ophthalmology. The company researches, develops, manufactures and markets prescription medicines and other products used to diagnose and treat eye diseases.

Its product portfolio includes ophthalmic treatments for conditions such as glaucoma, dry eye, allergic eye disease, ocular infections and retinal disorders. Santen also develops therapies for other vision-related conditions and provides products for eye-care professionals and patients.

Founded in 1890 and headquartered in Osaka, Japan, Santen serves patients and medical professionals through operations and commercial activities in Japan and international markets, including parts of Asia, Europe and other regions.